Click here to get full coverage on RIGL stock rises 59% in a year: Time to buy, hold or sell? - MSN

RIGL stock rises 59% in a year: Time to buy, hold or sell?  MSN

RIGL stock rises 59% in a year: Time to buy, hold or sell? - MSN

Click here to get full coverage on Rigel Pharmaceuticals: Growing Where It Matters (NASDAQ:RIGL) - Seeking Alpha

Rigel Pharmaceuticals: Growing Where It Matters (NASDAQ:RIGL)  Seeking Alpha

Rigel Pharmaceuticals: Growing Where It Matters (NASDAQ:RIGL) - Seeking Alpha

Click here to get full coverage on Rigel Provides Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - PR Newswire

Rigel Provides Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update  PR Newswire

Rigel Provides Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - PR Newswire

Click here to get full coverage on Rigel Pharmaceuticals (RIGL) Q4 Earnings Miss Estimates - Nasdaq

Rigel Pharmaceuticals (RIGL) Q4 Earnings Miss Estimates  Nasdaq

Rigel Pharmaceuticals (RIGL) Q4 Earnings Miss Estimates - Nasdaq

Click here to get full coverage on Rigel Pharmaceuticals (RIGL) Earnings Expected to Grow: Should You Buy? - Yahoo Finance

Rigel Pharmaceuticals (RIGL) Earnings Expected to Grow: Should You Buy?  Yahoo Finance

Rigel Pharmaceuticals (RIGL) Earnings Expected to Grow: Should You Buy? - Yahoo Finance

Click here to get full coverage on $RIGL stock is down 11% today. Here's what we see in our data. - Quiver Quantitative

$RIGL stock is down 11% today. Here's what we see in our data.  Quiver Quantitative

$RIGL stock is down 11% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Assessing Rigel Pharmaceuticals (RIGL) Valuation After Strong Q4 And Full Year 2025 Earnings Results - simplywall.st

Assessing Rigel Pharmaceuticals (RIGL) Valuation After Strong Q4 And Full Year 2025 Earnings Results  simplywall.st

Assessing Rigel Pharmaceuticals (RIGL) Valuation After Strong Q4 And Full Year 2025 Earnings Results - simplywall.st

Click here to get full coverage on Rigel Reports Third Quarter 2025 Financial Results and Provides Business Update - PR Newswire

Rigel Reports Third Quarter 2025 Financial Results and Provides Business Update  PR Newswire

Rigel Reports Third Quarter 2025 Financial Results and Provides Business Update - PR Newswire

Click here to get full coverage on Rigel Pharma stock slides on 2026 outlook (RIGL:NASDAQ) - Seeking Alpha

Rigel Pharma stock slides on 2026 outlook (RIGL:NASDAQ)  Seeking Alpha

Rigel Pharma stock slides on 2026 outlook (RIGL:NASDAQ) - Seeking Alpha

Click here to get full coverage on IOVA vs. RIGL: Which Small-Cap Biotech Has More Upside Potential? - Nasdaq

IOVA vs. RIGL: Which Small-Cap Biotech Has More Upside Potential?  Nasdaq

IOVA vs. RIGL: Which Small-Cap Biotech Has More Upside Potential? - Nasdaq

Click here to get full coverage on Why Analysts Say The Rigel Pharmaceuticals (RIGL) Story Is Shifting After Q3 And 2025 Guidance - Yahoo Finance

Why Analysts Say The Rigel Pharmaceuticals (RIGL) Story Is Shifting After Q3 And 2025 Guidance  Yahoo Finance

Why Analysts Say The Rigel Pharmaceuticals (RIGL) Story Is Shifting After Q3 And 2025 Guidance - Yahoo Finance

Click here to get full coverage on Rigel Presents Updated Data from the Ongoing Phase 1b Study Evaluating R289 in Patients with Lower-Risk MDS at the 67th ASH Annual Meeting and Exposition - PR Newswire

Rigel Presents Updated Data from the Ongoing Phase 1b Study Evaluating R289 in Patients with Lower-Risk MDS at the 67th ASH Annual Meeting and Exposition  PR Newswire

Rigel Presents Updated Data from the Ongoing Phase 1b Study Evaluating R289 in Patients with Lower-Risk MDS at the 67th ASH Annual Meeting and Exposition - PR Newswire

Click here to get full coverage on Rigel Announces First Patient Enrolled in the Dose Expansion Phase of its Phase 1b Study of R289 in Patients with Lower-Risk MDS - PR Newswire

Rigel Announces First Patient Enrolled in the Dose Expansion Phase of its Phase 1b Study of R289 in Patients with Lower-Risk MDS  PR Newswire

Rigel Announces First Patient Enrolled in the Dose Expansion Phase of its Phase 1b Study of R289 in Patients with Lower-Risk MDS - PR Newswire

Click here to get full coverage on Rigel Announces Publication of Final 5-year Data on REZLIDHIA® (olutasidenib) in Patients with R/R mIDH1 AML in the Journal of Hematology & Oncology - PR Newswire

Rigel Announces Publication of Final 5-year Data on REZLIDHIA® (olutasidenib) in Patients with R/R mIDH1 AML in the Journal of Hematology & Oncology  PR Newswire

Rigel Announces Publication of Final 5-year Data on REZLIDHIA® (olutasidenib) in Patients with R/R mIDH1 AML in the Journal of Hematology & Oncology - PR Newswire

Click here to get full coverage on Rigel Provides Business Update and 2026 Outlook - PR Newswire

Rigel Provides Business Update and 2026 Outlook  PR Newswire

Rigel Provides Business Update and 2026 Outlook - PR Newswire

Click here to get full coverage on Rigel Announces One Oral and Four Poster Presentations at the 67th American Society of Hematology Annual Meeting and Exposition - PR Newswire

Rigel Announces One Oral and Four Poster Presentations at the 67th American Society of Hematology Annual Meeting and Exposition  PR Newswire

Rigel Announces One Oral and Four Poster Presentations at the 67th American Society of Hematology Annual Meeting and Exposition - PR Newswire

Click here to get full coverage on Rigel Reports Second Quarter 2025 Financial Results and Provides Business Update - PR Newswire

Rigel Reports Second Quarter 2025 Financial Results and Provides Business Update  PR Newswire

Rigel Reports Second Quarter 2025 Financial Results and Provides Business Update - PR Newswire

Click here to get full coverage on Rigel Appoints Michael P. Miller to the Board of Directors - PR Newswire

Rigel Appoints Michael P. Miller to the Board of Directors  PR Newswire

Rigel Appoints Michael P. Miller to the Board of Directors - PR Newswire

Click here to get full coverage on Surging Earnings Estimates Signal Upside for Rigel (RIGL) Stock - MSN

Surging Earnings Estimates Signal Upside for Rigel (RIGL) Stock  MSN

Surging Earnings Estimates Signal Upside for Rigel (RIGL) Stock - MSN

Click here to get full coverage on Rigel Pharmaceuticals (RIGL) EPS Spike On Non Cash Gains Challenges Bullish Narratives - simplywall.st

Rigel Pharmaceuticals (RIGL) EPS Spike On Non Cash Gains Challenges Bullish Narratives  simplywall.st

Rigel Pharmaceuticals (RIGL) EPS Spike On Non Cash Gains Challenges Bullish Narratives - simplywall.st

Click here to get full coverage on Is Rigel Pharmaceuticals (RIGL) 2026 Revenue Guidance Reframing Its Commercial-Led Investment Narrative? - Yahoo Finance

Is Rigel Pharmaceuticals (RIGL) 2026 Revenue Guidance Reframing Its Commercial-Led Investment Narrative?  Yahoo Finance

Is Rigel Pharmaceuticals (RIGL) 2026 Revenue Guidance Reframing Its Commercial-Led Investment Narrative? - Yahoo Finance

Click here to get full coverage on Rigel Pharmaceuticals (RIGL) Tops Q3 Earnings and Revenue Estimates - Yahoo Finance

Rigel Pharmaceuticals (RIGL) Tops Q3 Earnings and Revenue Estimates  Yahoo Finance

Rigel Pharmaceuticals (RIGL) Tops Q3 Earnings and Revenue Estimates - Yahoo Finance

Click here to get full coverage on Rigel Pharmaceuticals (RIGL) Set to Report Q4 FY2025 Earnings After the Bell — Here’s What to Expect - AlphaStreet

Rigel Pharmaceuticals (RIGL) Set to Report Q4 FY2025 Earnings After the Bell — Here’s What to Expect  AlphaStreet

Rigel Pharmaceuticals (RIGL) Set to Report Q4 FY2025 Earnings After the Bell — Here’s What to Expect - AlphaStreet

Click here to get full coverage on Rigel Pharmaceuticals, Inc. (RIGL) Releases Preliminary Results for Q4 2025 - Yahoo Finance

Rigel Pharmaceuticals, Inc. (RIGL) Releases Preliminary Results for Q4 2025  Yahoo Finance

Rigel Pharmaceuticals, Inc. (RIGL) Releases Preliminary Results for Q4 2025 - Yahoo Finance

Click here to get full coverage on How The Narrative Around Rigel Pharmaceuticals (RIGL) Is Shifting With Raised Guidance And Cash Flow - Yahoo Finance

How The Narrative Around Rigel Pharmaceuticals (RIGL) Is Shifting With Raised Guidance And Cash Flow  Yahoo Finance

How The Narrative Around Rigel Pharmaceuticals (RIGL) Is Shifting With Raised Guidance And Cash Flow - Yahoo Finance

Click here to get full coverage on RIGL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

RIGL Financials: Income Statement, Balance Sheet & Cash Flow  Stock Titan

RIGL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Click here to get full coverage on Rigel Pharmaceuticals (RIGL) is a Great Momentum Stock: Should You Buy? - Yahoo Finance

Rigel Pharmaceuticals (RIGL) is a Great Momentum Stock: Should You Buy?  Yahoo Finance

Rigel Pharmaceuticals (RIGL) is a Great Momentum Stock: Should You Buy? - Yahoo Finance

Click here to get full coverage on Rigel Reports First Quarter 2025 Financial Results and Provides Business Update - PR Newswire

Rigel Reports First Quarter 2025 Financial Results and Provides Business Update  PR Newswire

Rigel Reports First Quarter 2025 Financial Results and Provides Business Update - PR Newswire

Click here to get full coverage on Rigel Pharmaceuticals (RIGL) Is Up 21.7% After Strong Q3 Results and Raised 2025 Guidance - Yahoo Finance

Rigel Pharmaceuticals (RIGL) Is Up 21.7% After Strong Q3 Results and Raised 2025 Guidance  Yahoo Finance

Rigel Pharmaceuticals (RIGL) Is Up 21.7% After Strong Q3 Results and Raised 2025 Guidance - Yahoo Finance

Click here to get full coverage on Rigel Pharmaceuticals Inc (RIGL) Q4 2025 Earnings Call Highlights: Record Net Income and Strategic Growth Initiatives - GuruFocus

Rigel Pharmaceuticals Inc (RIGL) Q4 2025 Earnings Call Highlights: Record Net Income and Strategic Growth Initiatives  GuruFocus

Rigel Pharmaceuticals Inc (RIGL) Q4 2025 Earnings Call Highlights: Record Net Income and Strategic Growth Initiatives - GuruFocus

Click here to get full coverage on A Look At Rigel Pharmaceuticals (RIGL) Valuation After Issuing 2026 Revenue Guidance - Yahoo Finance

A Look At Rigel Pharmaceuticals (RIGL) Valuation After Issuing 2026 Revenue Guidance  Yahoo Finance

A Look At Rigel Pharmaceuticals (RIGL) Valuation After Issuing 2026 Revenue Guidance - Yahoo Finance

Click here to get full coverage on Rigel Pharmaceuticals (NASDAQ:RIGL) Posts Quarterly Earnings Results, Misses Estimates By $0.19 EPS - MarketBeat

Rigel Pharmaceuticals (NASDAQ:RIGL) Posts Quarterly Earnings Results, Misses Estimates By $0.19 EPS  MarketBeat

Rigel Pharmaceuticals (NASDAQ:RIGL) Posts Quarterly Earnings Results, Misses Estimates By $0.19 EPS - MarketBeat

Click here to get full coverage on Rigel Pharmaceuticals (RIGL) Is Down 7.7% After Issuing Detailed 2026 Revenue Mix Guidance – Has The Bull Case Changed? - simplywall.st

Rigel Pharmaceuticals (RIGL) Is Down 7.7% After Issuing Detailed 2026 Revenue Mix Guidance – Has The Bull Case Changed?  simplywall.st

Rigel Pharmaceuticals (RIGL) Is Down 7.7% After Issuing Detailed 2026 Revenue Mix Guidance – Has The Bull Case Changed? - simplywall.st

Click here to get full coverage on Rigel Pharmaceuticals (RIGL) Projects Revenue Decline for 2026 - GuruFocus

Rigel Pharmaceuticals (RIGL) Projects Revenue Decline for 2026  GuruFocus

Rigel Pharmaceuticals (RIGL) Projects Revenue Decline for 2026 - GuruFocus

Click here to get full coverage on What Makes Rigel Pharmaceuticals (RIGL) a Strong Momentum Stock: Buy Now? - Yahoo Finance

What Makes Rigel Pharmaceuticals (RIGL) a Strong Momentum Stock: Buy Now?  Yahoo Finance

What Makes Rigel Pharmaceuticals (RIGL) a Strong Momentum Stock: Buy Now? - Yahoo Finance

Click here to get full coverage on Rigel Pharmaceuticals Inc (RIGL) Q3 2025 Earnings Call Highlights: Record Revenue and Raised ... - Yahoo Finance

Rigel Pharmaceuticals Inc (RIGL) Q3 2025 Earnings Call Highlights: Record Revenue and Raised ...  Yahoo Finance

Rigel Pharmaceuticals Inc (RIGL) Q3 2025 Earnings Call Highlights: Record Revenue and Raised ... - Yahoo Finance

Click here to get full coverage on Rigel Pharmaceuticals Inc (RIGL) Q3 2025 Earnings Report Preview: What to Expect - Yahoo Finance

Rigel Pharmaceuticals Inc (RIGL) Q3 2025 Earnings Report Preview: What to Expect  Yahoo Finance

Rigel Pharmaceuticals Inc (RIGL) Q3 2025 Earnings Report Preview: What to Expect - Yahoo Finance

Click here to get full coverage on Rigel (RIGL) Loses 27.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance

Rigel (RIGL) Loses 27.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner  Yahoo Finance

Rigel (RIGL) Loses 27.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance

Click here to get full coverage on Rigel Pharmaceuticals (RIGL) Price Target Increased by 11.74% to 43.69 - Nasdaq

Rigel Pharmaceuticals (RIGL) Price Target Increased by 11.74% to 43.69  Nasdaq

Rigel Pharmaceuticals (RIGL) Price Target Increased by 11.74% to 43.69 - Nasdaq

Click here to get full coverage on RIGL vs. FOLD: Which Biotech Stock Offers Better Growth Potential? - Yahoo Finance

RIGL vs. FOLD: Which Biotech Stock Offers Better Growth Potential?  Yahoo Finance

RIGL vs. FOLD: Which Biotech Stock Offers Better Growth Potential? - Yahoo Finance

Click here to get full coverage on Rigel Pharmaceuticals: Continued Financial Performance, Catalysts In 2026 (RIGL) - Seeking Alpha

Rigel Pharmaceuticals: Continued Financial Performance, Catalysts In 2026 (RIGL)  Seeking Alpha

Rigel Pharmaceuticals: Continued Financial Performance, Catalysts In 2026 (RIGL) - Seeking Alpha

Click here to get full coverage on Rigel Pharmaceuticals, Inc. (RIGL) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance

Rigel Pharmaceuticals, Inc. (RIGL) Hit a 52 Week High, Can the Run Continue?  Yahoo Finance

Rigel Pharmaceuticals, Inc. (RIGL) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance

Click here to get full coverage on FOLD vs. RIGL: Which Rare Disease Biotech Stock Has Better Upside? - Yahoo Finance

FOLD vs. RIGL: Which Rare Disease Biotech Stock Has Better Upside?  Yahoo Finance

FOLD vs. RIGL: Which Rare Disease Biotech Stock Has Better Upside? - Yahoo Finance

Click here to get full coverage on Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - PR Newswire

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)  PR Newswire

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - PR Newswire

Click here to get full coverage on Rigel Pharmaceuticals (RIGL) Projects FY26 Revenue Growth - GuruFocus

Rigel Pharmaceuticals (RIGL) Projects FY26 Revenue Growth  GuruFocus

Rigel Pharmaceuticals (RIGL) Projects FY26 Revenue Growth - GuruFocus

Click here to get full coverage on Rigel Pharmaceuticals (RIGL) Profitability Rebound Reinforces Bullish Valuation Narratives - Yahoo Finance

Rigel Pharmaceuticals (RIGL) Profitability Rebound Reinforces Bullish Valuation Narratives  Yahoo Finance

Rigel Pharmaceuticals (RIGL) Profitability Rebound Reinforces Bullish Valuation Narratives - Yahoo Finance

Click here to get full coverage on Rigel Pharmaceuticals: Behind The Huge Rally (NASDAQ:RIGL) - Seeking Alpha

Rigel Pharmaceuticals: Behind The Huge Rally (NASDAQ:RIGL)  Seeking Alpha

Rigel Pharmaceuticals: Behind The Huge Rally (NASDAQ:RIGL) - Seeking Alpha

Click here to get full coverage on Rigel Pharmaceuticals (RIGL) Projected to Post Earnings on Tuesday - MarketBeat

Rigel Pharmaceuticals (RIGL) Projected to Post Earnings on Tuesday  MarketBeat

Rigel Pharmaceuticals (RIGL) Projected to Post Earnings on Tuesday - MarketBeat

Click here to get full coverage on Rigel Pharmaceuticals' (NASDAQ:RIGL) Earnings Are Of Questionable Quality - Yahoo Finance

Rigel Pharmaceuticals' (NASDAQ:RIGL) Earnings Are Of Questionable Quality  Yahoo Finance

Rigel Pharmaceuticals' (NASDAQ:RIGL) Earnings Are Of Questionable Quality - Yahoo Finance

Click here to get full coverage on Rigel Pharma (RIGL) Earnings Call Transcript - The Globe and Mail

Rigel Pharma (RIGL) Earnings Call Transcript  The Globe and Mail

Rigel Pharma (RIGL) Earnings Call Transcript - The Globe and Mail

Click here to get full coverage on Should Value Investors Buy Rigel Pharmaceuticals (RIGL) Stock? - Nasdaq

Should Value Investors Buy Rigel Pharmaceuticals (RIGL) Stock?  Nasdaq

Should Value Investors Buy Rigel Pharmaceuticals (RIGL) Stock? - Nasdaq

Click here to get full coverage on Rigel Stock: Formulating A Game Plan For 2026 (NASDAQ:RIGL) - Seeking Alpha

Rigel Stock: Formulating A Game Plan For 2026 (NASDAQ:RIGL)  Seeking Alpha

Rigel Stock: Formulating A Game Plan For 2026 (NASDAQ:RIGL) - Seeking Alpha

Click here to get full coverage on Rigel Pharmaceuticals Inc (RIGL) Q2 2025 Earnings Call Highlights: Record Revenue and Raised ... - Yahoo Finance

Rigel Pharmaceuticals Inc (RIGL) Q2 2025 Earnings Call Highlights: Record Revenue and Raised ...  Yahoo Finance

Rigel Pharmaceuticals Inc (RIGL) Q2 2025 Earnings Call Highlights: Record Revenue and Raised ... - Yahoo Finance

Click here to get full coverage on All You Need to Know About Rigel (RIGL) Rating Upgrade to Strong Buy - Nasdaq

All You Need to Know About Rigel (RIGL) Rating Upgrade to Strong Buy  Nasdaq

All You Need to Know About Rigel (RIGL) Rating Upgrade to Strong Buy - Nasdaq

Click here to get full coverage on Responsive Playbooks and the RIGL Inflection - Stock Traders Daily

Responsive Playbooks and the RIGL Inflection  Stock Traders Daily

Responsive Playbooks and the RIGL Inflection - Stock Traders Daily

Click here to get full coverage on H.C. Wainwright Reiterates a Buy Rating on Rigel Pharmaceuticals (RIGL), Sets a $57 PT - Yahoo Finance

H.C. Wainwright Reiterates a Buy Rating on Rigel Pharmaceuticals (RIGL), Sets a $57 PT  Yahoo Finance

H.C. Wainwright Reiterates a Buy Rating on Rigel Pharmaceuticals (RIGL), Sets a $57 PT - Yahoo Finance

Click here to get full coverage on What Does Wall Street Think About Rigel Pharmaceuticals (RIGL)? - Yahoo Finance

What Does Wall Street Think About Rigel Pharmaceuticals (RIGL)?  Yahoo Finance

What Does Wall Street Think About Rigel Pharmaceuticals (RIGL)? - Yahoo Finance

Click here to get full coverage on Rigel Pharma: Q3 Earnings Showcase Robust Growth (NASDAQ:RIGL) - Seeking Alpha

Rigel Pharma: Q3 Earnings Showcase Robust Growth (NASDAQ:RIGL)  Seeking Alpha

Rigel Pharma: Q3 Earnings Showcase Robust Growth (NASDAQ:RIGL) - Seeking Alpha

Click here to get full coverage on Analysts Offer Insights on Healthcare Companies: Rigel (RIGL), Arcturus Therapeutics (ARCT) and Intellia Therapeutics (NTLA) - The Globe and Mail

Analysts Offer Insights on Healthcare Companies: Rigel (RIGL), Arcturus Therapeutics (ARCT) and Intellia Therapeutics (NTLA)  The Globe and Mail

Analysts Offer Insights on Healthcare Companies: Rigel (RIGL), Arcturus Therapeutics (ARCT) and Intellia Therapeutics (NTLA) - The Globe and Mail

Click here to get full coverage on Rigel Pharmaceuticals, Inc. (RIGL) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance

Rigel Pharmaceuticals, Inc. (RIGL) Hits Fresh High: Is There Still Room to Run?  Yahoo Finance

Rigel Pharmaceuticals, Inc. (RIGL) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance

Click here to get full coverage on Can RIGL's Oncology Portfolio Create Long-Term Value Beyond Tavalisse? - Yahoo Finance

Can RIGL's Oncology Portfolio Create Long-Term Value Beyond Tavalisse?  Yahoo Finance

Can RIGL's Oncology Portfolio Create Long-Term Value Beyond Tavalisse? - Yahoo Finance

Click here to get full coverage on Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) Price Is Right But Growth Is Lacking After Shares Rocket 35% - simplywall.st

Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) Price Is Right But Growth Is Lacking After Shares Rocket 35%  simplywall.st

Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) Price Is Right But Growth Is Lacking After Shares Rocket 35% - simplywall.st

Click here to get full coverage on Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update - Finviz

Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update  Finviz

Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update - Finviz

Click here to get full coverage on Rigel Pharmaceuticals Inc (RIGL) Q2 2025 Earnings Report Preview: What To Look For - Yahoo Finance

Rigel Pharmaceuticals Inc (RIGL) Q2 2025 Earnings Report Preview: What To Look For  Yahoo Finance

Rigel Pharmaceuticals Inc (RIGL) Q2 2025 Earnings Report Preview: What To Look For - Yahoo Finance

Click here to get full coverage on Rigel to Present at the Jefferies Global Healthcare Conference in London - PR Newswire

Rigel to Present at the Jefferies Global Healthcare Conference in London  PR Newswire

Rigel to Present at the Jefferies Global Healthcare Conference in London - PR Newswire

Click here to get full coverage on Rigel Pharmaceuticals, Inc. (RIGL) Stock Analysis: Unpacking a 49% Potential Upside for Investors - DirectorsTalk Interviews

Rigel Pharmaceuticals, Inc. (RIGL) Stock Analysis: Unpacking a 49% Potential Upside for Investors  DirectorsTalk Interviews

Rigel Pharmaceuticals, Inc. (RIGL) Stock Analysis: Unpacking a 49% Potential Upside for Investors - DirectorsTalk Interviews

Click here to get full coverage on Can RIGL's Oncology Portfolio Create Long-Term Value Beyond Tavalisse? - Nasdaq

Can RIGL's Oncology Portfolio Create Long-Term Value Beyond Tavalisse?  Nasdaq

RIGL

Price Chart

Key Statistics

Technicals

About RIGL

Latest News

RIGL stock rises 59% in a year: Time to buy, hold or sell? - MSN

Rigel Pharmaceuticals: Growing Where It Matters (NASDAQ:RIGL) - Seeking Alpha

Rigel Provides Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - PR Newswire

Advanced Charts

Top Gainers

Top Losers